hyperuricaemia
Table of Contents
Hyperuricaemia
see also:
Introduction
aetiology:
- the major cause of the rising prevalence in Western societies is perhaps the increasing intake of fructose
- in general hyperuricaemia is caused by either or combined:
- decreased renal excretion
- increased uric acid production
- increased fructose intake - this generates uric acid and may reduce renal excretion
- etc
- high purine intake
- GIT microbiota affects on GIT uric acid and purine metabolism as well as uric acid absorption
oncologic settings:
- acute tumour lysis syndrome: post chemo of acute leukaemias and lymphomas
- multiple myeloma
- disseminated metastatic carcinoma
associated non-malignant conditions
- renal failure of any cause + diuretics
- elevated serum uric acid levels are associated with the onset of chronic kidney disease [OR = 2.35 (1.59–3.46)] 2)
- associations but causal link as yet unproven:
-
- for every 1 mg/dl increase in serum UA, the relative risk of HTN increased 1.13 times 3)
-
- asymptomatic hyperuricemia is an independent risk factor for T2DM and insulin resistance [HR = 1.87 (1.33–2.62) and 1.36 (1.23–1.51) 4)
-
- patients with acute myocardial infarction showed that patients with hyperuricemia are more likely to have major adverse cardiac events [RR = 3.44 (2.33–5.08)] and in-hospital mortality [RR = 2.10 (1.03–4.26)] 5)
summary:
- serious and if recognised early, results in significant reduction in morbidity
- pathogenesis: increased production, decreased excretion
- major source is cell breakdown
- major excretory PW is renal
- with increased uric acid in kidneys ⇒ crystals in distal tubules ⇒ intrarenal obstruction ⇒ ARF
- chronically elevated levels: renal colic, obstructive uropathy, CRF
May cause 3 types of renal disease:
- acute hyperuricaemic nephropathy
- uric acid nephrolithiasis
- gouty nephropathy
symptoms & signs in the oncologic patient:
- +/- asymptomatic
- underlying malignancy
- with symptoms of tumour lysis syndrome
- acute oliguria following chemotherapy
- renal colic
investigations:
- serum uric acid
- U + E
management in the oncologic patient:
- pretreat hyperuricaemia- prior to chemo or XRT
- hydration
- consider Na Bicarbonate (alkalinise urine), diuretics
- mannitol
- peritoneal dialysis/haemodialysis
management in the patient with gout
- see gout
hyperuricaemia.txt · Last modified: 2023/07/20 13:11 by gary1